Fluorescent angiography used as a tool to guide angiosome-directed endovascular therapy for diabetic foot ulcers

Marshall Dworak, Elizabeth A. Andraska, S. Michael Gharacholou, Melissa Myers, Scott C. Chapman

Research output: Contribution to journalArticlepeer-review

Abstract

Angiosome-directed endovascular therapy for the treatment of chronic limb-threatening ischemia (CLTI) remains controversial owing to the overlap of wound angiosomes. Angiographic grading of success has limitations and translesional pressure assessments are seldom performed in the infrapopliteal vessels. Objective criteria to determine revascularization success in tibiopedal vessels have not been well described. Quantifying perfusion to a wound bed after establishing direct or indirect (via collateral) flow after revascularization is an important component for treating CLTI patients yet is seldom performed. We report the use of fluorescent angiography to quantitatively examine perfusion of a diabetic foot ulcer before and after angiosome-directed endovascular therapy.

Original languageEnglish (US)
Pages (from-to)159-163
Number of pages5
JournalJournal of Vascular Surgery Cases and Innovative Techniques
Volume7
Issue number1
DOIs
StatePublished - Mar 2021

Keywords

  • Angiosome-directed endovascular therapy
  • Fluorescent angiography

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Fluorescent angiography used as a tool to guide angiosome-directed endovascular therapy for diabetic foot ulcers'. Together they form a unique fingerprint.

Cite this